AKT in cancer: new molecular insights and advances in drug development
Prabhjot S. Mundi(Columbia University Irving Medical Center), Kevin Kalinsky(Emory University), Jasgit C. Sachdev(HonorHealth), Carolyn K. McCourt(Gynecologic Oncology Group)
Cited by 267
Related Papers
Current Landscape of Immunotherapy in Breast Cancer
|JAMA Oncology|2019|409
Resistance to neoadjuvant chemotherapy in triple-negative breast cancer mediated by a reversible drug-tolerant state
|Science Translational Medicine|2019|316
Inavolisib-Based Therapy in <i>PIK3CA</i> -Mutated Advanced Breast Cancer
|New England Journal of Medicine|2024|235
Biomarkers for Systemic Therapy in Metastatic Breast Cancer: ASCO Guideline Update
|Journal of Clinical Oncology|2022|127